COMPANY PROFILE

Cambiotics

Explore full profile

Supports the natural removal process of forever chemicals from the body

Copenhagen, DenmarkFounded 2024Biotech & Life Sciences

Valuation $0–100M Latest valuation · 2026

Headcount <100 Current team size

Total funding $0–10M Disclosed equity funding

Unlock exact values

At a glance

Status: Operational
Founded: 2024
Headquarters: Copenhagen, Denmark
Employees: 11
Open positions: None listed
Dealroom signal: 78.5/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, Woman Founder, PFAS, DT and LS, UKSU, UKSU2010, science-based
Client focus: b2b
Links: Website LinkedIn

Latest news

Press, funding announcements and product moves mentioning Cambiotics.

See all news

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Feb 2026	$4.4M	$18M	True. · Export and Investment Fund of Denmark · Collaborative Fund	↗
SPINOUT✓Other financing	Jan 2024	$0	—	University of Cambridge	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Cambiotics website traffic

Latest recorded traffic for Cambiotics is 3.2K monthly website visits, down 3% over the last three months. Cambiotics's team grew 57.1% over the past year.

Latest monthly visits3.2K 3-month web change-3% 1-year team growth+57.1%

Monthly website visitsJul 2025–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SASansanimaHuman cell-based assays replacing animal testing.	Sheffield, United Kingdom	Operational	5	$396K	$1.6M
DTDraig TherapeuticsTargeted neuromodulators for major neuropsychiatric disorders treatment	Cardiff, United Kingdom	Operational
CHCellestial HealthPioneering brain disease treatment by targeting astrocytic networks with sustainable pharmaceutical practices	Cambridge, United Kingdom	Operational
KTKodiform TherapeuticsA drug discovery company with an initial focus on cancer	London, United Kingdom	Operational
SPSpliceorRNA trans-splicing gene therapies for aggressive cancers	Cambridge, United Kingdom	Operational
CTCrucible TherapeuticsRNA-targeting therapies for debilitating neurodegenerative diseases	Sheffield, United Kingdom	Operational
AVAviadoBioPrecision gene therapies for neurodegenerative disorders	London, United Kingdom	Operational
RTResolution TherapeuticsMacrophage cell therapies for inflammatory organ diseases	Edinburgh, United Kingdom	Operational